Mike Honey Profile picture
Sep 15 13 tweets 4 min read Read on X
New variant MV.1 is spreading quite rapidly, and looks a potential next challenger against the now-dominant DeFLuQE variants (KP.3.1.1 and descendants), perhaps rivalling XEC.

MV.1 first appeared in Maharashtra, India in late June.
🧵
The story might've ended there, but after almost a month the next sample was recorded. It has since spread quite rapidly to 9 countries on 4 continents. Around 40 samples have now been reported.
🧵
In North America, MV.1 has mostly been reported in the north-east US. In Canada; Ontario and BC have reported the first samples.
🧵 Image
In Europe, MV.1 was first reported in Portugal, then Scotland, then Ireland and the Netherlands.
🧵 Image
MV.1 is descended from JN.1.49 by way of MB.1.1.1. That long evolutionary path has been most successful in samples from India, without any notable success elsewhere.

MV.1 reverts the Spike K478T mutation to the ancestral (Wuhan) type.
🧵
Globally, MV.1 is showing a competitive growth advantage of 4.4% per day (31% per week) over JN.1.* + DeFLuQE variants. This is just a shade slower than XEC's current global pace.
🧵 Image
Here's a table of weekly frequencies for MV.1 by geography (continents and/or countries).  Note the recent data from India is very thin and lags by many weeks.
🧵 Image
There is apparently very strong growth reported for the US, but the data from the US is often heavily skewed by pooled samples and samples from travellers in the early spread phase of recent variants.
🧵
In this detailed comment, Ryan Hisner highlighted the super-rare nucleotide mutation T29637A, featured in MV.1 ancestor MB.1:

🧵github.com/sars-cov-2-var…
h/t to Variant Hunters and for the tricky GISAID search for MV.1:
C936T,-22995A,T3565C,G7393T
Or
MB.1.1 with -22995A and ORF1a:T224I
🧵x.com/xz_keg
x.com/siamosolocani
-22995A means that mutation was reverted back to the ancestral type.  In my dataviz, fueled by Nextclade output, -22995A is represented as A22995C.
🧵
As the MV.1 designation has not flowed through into Nextclade, I am approximating it above by searching for it's characteristic mutations.

Interactive mutation matching dataviz, code, acknowledgements and more info here:

🧵endsgithub.com/Mike-Honey/sar…
PS: wrt to the maps:

Locations are approximate - typically country and state/province.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Mike Honey

Mike Honey Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @Mike_Honey_

Aug 29
Recombinant variant XEC is continuing to spread, and looks a likely challenger against the now-dominant DeFLuQE variants (KP.3.1.1 and descendants).

Here are the leading countries reporting XEC. A chain of samples were reported from Slovenia during August, reaching 12%.
🧵 Image
XEC first appeared in Berlin in late June.  It has since spread quite rapidly across Europe, North America and Asia. Around 180 samples have now been reported, from 18 countries on 3 continents. Belgium, Hong Kong and Japan reported their first samples in the last week or so.
🧵 Image
XEC is a mix of KS.1.1 (FLiRT, although XEC did not get the R346T mutation) and KP.3.3 (FLuQE). XEC might have an advantage from it's unusual T22N mutation, in combination with the FLuQE mutations.
🧵
Read 6 tweets
Aug 27
Having grown up in NZ and lived in the UK for a year I'm proud (and lucky) to be able to choose Australia as my home.

IMO a fair chunk of our advantage is down policy differences, but wealth is probably also significant.
🧵
Australia was #1 in the world for median wealth (now #2 by a tiny margin), and well clear of the other anglophone countries. This gives more Australians a relaxed lifestyle, with the freedom to worry less about finances.
🧵
visualcapitalist.com/wp-content/upl…
Image
Policy-wise, I think Australia is leading on the topics of:
- smoking
- drug use
- road safety
- firearms

These seem reflected in (or reflect) differences in general attitudes on these topics, e.g. driving style seems far less aggressive than in other anglo countries.
🧵
Read 6 tweets
Aug 25
Recombinant variant XEC is continuing to spread, and looks a likely next challenger against the now-dominant DeFLuQE variants (KP.3.1.1 and descendants).
🧵 Image
XEC first appeared in Berlin in late June.  It has since spread quite rapidly across Europe, North America and Asia.

Around 111 samples have now been reported, from 15 countries on 3 continents. Israel and Spain have reported their first samples in the last week.
🧵
XEC is a mix of KS.1.1 (FLiRT, although XEC did not get the R346T mutation) and KP.3.3 (FLuQE). XEC might have an advantage from it's unusual T22N mutation, in combination with the FLuQE mutations.
🧵
Read 7 tweets
Aug 17
Here's a look at the volume of genomic sequencing data in GISAID, by submission date For 2024. It has been running at 33,000 - 53,000 per month, so over 1,000 per day. July was a relatively high-volume month, and August looks on track to also deliver strong volumes.
🧵 Image
The chart below tracks the median delay between sample collection and submission to GISAID.  This is holding steady at 20-30 days.
🧵
Here's a map of the sequences collected in 2024.  There are some countries/regions with low/no sequencing data, mostly in Africa and the Middle East. But otherwise there is some coverage from most countries/regions.
🧵 Image
Read 7 tweets
Aug 17
Recombinant variant XEC is continuing to spread very rapidly, and looks a likely next challenger against the now-dominant DeFLuQE variants (KP.3.1.1 and descendants).
🧵 Image
XEC first appeared in Berlin in late June.  It has since spread quite rapidly across Europe, North America and Asia. Around 78 samples have now been reported, from 12 countries on 3 continents. Taiwan has reported it's first sample in the last week.
🧵
XEC is a mix of KS.1.1 (FLiRT, although XEC did not get the R346T mutation) and KP.3.3 (FLuQE). XEC might have an advantage from it's unusual T22N mutation, in combination with the FLuQE mutations.
🧵
Read 7 tweets
Aug 9
With DeFLuQE variants dominant or taking over now in most places, it is time to ponder which variant will drive the next wave.

A new leading candidate is recombinant XEC - a potent mix of KS.1.1 (FLiRT) and KP.3.3 (FLuQE).

This first appeared in Berlin in late June.  
🧵 Image
Globally, XEC is showing a robust growth advantage of 4.6% per day (32% per week) over JN.1.* + DeFLuQE variants. This is fastest growth of any contender I am aware of. As the starting frequencies are quite low, any crossover looks like happening in September or later.
🧵
Image
Image
Note that as I showed recently, DeFLuQE is showing the strongest recent growth from the Global perspective, and looks poised to take over dominance shortly:

🧵
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(